研究業績

論文

2024年

  1. Biswas S, Kuwata T, Yamauchi S, Okazaki K, Kaku Y, Hasan Md Z, Morioka H, Matsushita S.
    Idiotopes of antibodies against HIV-1 CD4-induced epitope shared with those against microorganisms.
    Immunology 171, 534-548 (2024). doi: 10.1111/imm.13742.
  2. Nakamura T, Ohyama C, Sakamoto M, Toma T, Tateishi H, Matsuo M, Chirifu M, Ilemizu S, Morioka H, Fujita M, Inouue J, Yamagata Y.
    TIFAB regulates the TIFA-TRAF6 signaling pathway involved in innate immunity by forming a heterodimer complex with TIFA.
    Proc. Natl. Acad. Sci. USA 121, e2318794121 (2024). doi: 10.1073/pnas.2318794121
  3. Du Y, Kobashigawa Y, Okazaki K, Ogawa M, Kawaguchi T, Sato T, Morioka H.
    Structure-based design, biophysical characterization, and biochemical application of the heterodimeric affinity purification tag based on the Schistosoma japonicum glutathione-S-transferase (SjGST) homodimer.
    J. Biochem. 175, in press. doi: 10.1093/jb/mvae028. Online Mar. 12, 2024.
  4. Kamesawa S, Ogawa M, Funakoshi Y, Kato M, Kai S, Namikawa M, Okazaki K, Sato T, Kobashigawa Y, Morioka H.
    Evaluation of the cyclic single-chain Fv antibody derived from nivolumab by biophysical analyses and in vitro cell-based bioassay.
    J. Biochem. 175, in press. doi: 10.1093/jb/mvae034. Online Apr. 9, 2024.
  5. Nakamura Y, Watanabe H, Nakamura T, Chirifu M, Ishiodori K, Imafuku T, Maeda H, Kobashigawa Y, Morioka H, Maruyama T.
    Contribution of Phe112, Ser114, and Tyr115 to Drug-Binding Selectivity in the A Variant of α1-Acid Glycoprotein
    Mol Pharm. 2024 Aug 5;21(8):4038-4046. doi: 10.1021/acs.molpharmaceut.4c00428. Epub 2024 Jul 1.
前のページに戻る